Table 3. Application of the Interrupted Time Series to measure the impact on the detection of sensitive and resistant TB. Ribeirão Preto, SP, Brazil, 2006-2017.
| INTERVENCIÓN | POSINTERVENCIÓN* | |||||
|---|---|---|---|---|---|---|
| Variables | Coefficient (95% CI)* | Trend | APC†
(95 CI)* |
Coefficient (95% CI)* | Trend | APC†
(95 CI)* |
| General tuberculosis | -0.018 (-0.133; 0.096) |
Stationary | - | 0.001 (-0.003; 0.005) |
Stationary | - |
| Pulmonary tuberculosis | -0.026 (-0.149; 0.097) |
Stationary | - | 0.003 (-0.001; 0.007) |
Stationary | - |
| Tuberculosis in children | 0.005 (-0.270; 0.281) |
Stationary | - | -0.004 (-0.015; 0.006) |
Stationary | - |
| Extrapulmonary tuberculosis | 0.108 (-0.093; 0.309) |
Stationary | - | -0.004 (-0.012; 0.003) |
Stationary | - |
| TB-HIV co-infection§ | -0.027 (-0.221; 0.166) |
Stationary | - | -0.001 (-0.009; 0.005) |
Stationary | - |
| Resistant tuberculosis | -0.040 (-0.090; 0.010) |
Stationary | - | 0.003 (0.001; 0.005) |
Increasing | 0.6%(0.23; 1.15) |
*
Post-Intervention: Beginning of the Rapid Molecular Test for Tuberculosis through the GeneXpert® MTB/RIF system in November 2014;
†
95% CI = 95% Confidence Interval;
‡APC = Annual Percent Change;
§
TB-HIV Coinfection = Tuberculosis and Human Immunodeficiency Virus co-infection